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INTRODUCTION: 
Over the last five decades, it was a common notion among dentists that periodontal 
infections were localized only to the intraoral sites and that they had very rare effects 
on the systemic health of the individual. It has now become a widely accepted truth, 
after evidence based studies that patients presenting with periodontitis have an 
increased incidence of systemic problems as well, and there seemed to be a positive 
correlation between periodontitis and problems of the cardiovascular, respiratory, 
endocrine systems and also presented adverse consequences on the outcome of 
pregnancy
1
. 
Among the chronic infections in humans, periodontal disease is one of the most 
widespread varieties. It occurs as a result of the host inflammatory cells acting on the 
source of infection which usually is predominantly gram negative bacterial in nature. 
The cell wall components such as lipopolysaccharide (LPS) generate such an 
inflammatory response
2
. The products of this reaction may also invade periodontal 
tissue and gain entry into the systemic circulation. Thus the immune system gets 
activated and the lipid metabolism is deregulated as a result, finally leading to 
increased expression of cytokines which mediate the inflammation
3
. 
In the etiology of cardiovascular disease (CVD), Hyperlipidemia is considered one of 
the major risk factors
4
. The reports of World Health Organization (WHO) (2006) have 
cited CVD as one of the chief causes of mortality worldwide. A vast majority of cases 
of CVD and stroke are caused by atherosclerotic vascular disease. Modern living 
lifestyle, lack of physical exercise, age, smoking habit, diet, obesity, lack of physical 
exercise have all been proved as predisposing factors for an altered lipid profile. The 
commencement of atherosclerotic plaque is attributed to the localized build-up of 
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lipids. The crucial role of plasma lipids in the initiation and progress of 
atherosclerosis is thus established
5
.  
In this regard, some common inflammatory diseases including periodontitis have been 
hypothesized to promote atherogenesis and increase the risk of cardiovascular and 
cerebrovascular events by virtue of a continuous release of chronic inflammatory 
mediators into systemic circulation
1
. Over the last 15 years, literature points toward a 
possible association between periodontal disease and increased incidence of 
cardiovascular disease. Thus it may be observed that periodontitis and cardiovascular 
disease have certain common risk factors such as diabetes, smoking, aging, male 
population, behavioural factors. 
Disturbances in the serum lipid profile, such as elevated blood concentrations of total 
cholesterol (TC), triglycerides (TG), and low-density lipoprotein- cholesterol (LDL-
C), and decreased levels of high-density lipoprotein cholesterol (HDL-C) serve as one 
of the key factors strongly linked to the pathophysiology of CVD
 6
. Lipid interaction 
with the cell membrane of macrophage interferes with membrane-bound receptors and 
enzyme systems. It alters macrophage gene expression for essential polypeptide 
growth factors and pro-inflammatory cytokines, namely tumour necrosis factor-alpha 
(TNF-α) and interleukin (IL)-1β, which are associated with periodontal disease5. 
Increased levels of total cholesterol; low and very low density lipoprotein cholesterol 
and triglycerides are usually observed in patients with chronic periodontitis. It was 
shown that periodontitis reduces the level of circulating high density lipoprotein 
(HDL) which presents a potent anti- atherogenic property
7
. Tumour necrosis factor 
(TNF) induces a rapid elevation in very low density lipoprotein (VLDL) levels, 
trigylcerides and cholesterol levels. TNF increases serum cholesterol levels by 
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mechanisms unknown. But the increase of cholesterol synthesis in the liver may be 
attributed to an increase in the activity of 3-hydroxy-3-methyl glutaryl coenzyme A 
(HMG-CoA) reductase
8
. 
Periodontal treatment involves a preliminary nonsurgical debridement. This procedure 
is followed by a re-evaluation, where the need for subsequent treatment is determined. 
The necessity for a surgical therapy is established at this stage. Nonsurgical 
periodontal therapy conventionally consists of supra and subgingival tooth 
debridement with the use of mechanical devices and instruction in self-administered 
oral health care measures. In patients with advanced periodontitis, hand 
instrumentation, ultrasonic, and sonic instrumentation appear to cause similar clinical 
improvements. The aim of periodontal instrumentation lies in effective removal of 
plaque and calculus without excessively instrumenting the tooth surfaces
9
. 
The earlier assumption that chronic destructive periodontal disease was a localized 
inflammatory disease has now become obsolete. It is now recognized as a common 
condition which has a wide impact on a variety of medical diseases and has a 
significant systemic implication. Chronic periodontitis has been elucidated as a risk 
factor for CVD, bacterial pneumonia, stroke, diabetes (Ryan 2006
10
). It would thus be 
logical to question the validity of periodontal therapy and reducing local inflammation 
in effectively reducing the risk for CVD
11
. In this regard, several studies have been 
conducted and to investigate whether periodontal therapy comprising of scaling and 
root planing (SRP) reduced the levels of biomarkers indicative of systemic 
inflammation in circulation. Certain studies showed that periodontal therapy reduced 
the plasma levels of C - reactive protein (CRP) significantly over 6 weeks (Mattilla et 
al. 2002
12
)
 
and some presented similar findings albeit over different time periods such 
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as 6 months (D’Aiuto et al. 200413). However, other studies (Ide et al. 200314, 
Yamazaki et al. 2005
15
) concluded that systemic biomarkers were not significantly 
changed following periodontal therapy consisting of SRP
16
. 
The present study was carried out to evaluate the levels of lipid profile in patients 
with chronic periodontitis before and after scaling and root planing. 
AIM AND OBJECTIVES 
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AIM: 
To estimate the levels of lipid profile in patients with chronic periodontitis before and 
after scaling and root planing - a comparative study. 
OBJECTIVES OF THE STUDY: 
1. To assess the lipid levels of the subjects with chronic periodontitis before scaling 
and root planing. 
2. To assess the lipid levels of the subjects with chronic periodontitis 6 weeks after 
scaling and root planing. 
3. To compare  the plaque index, gingival index, sulcular bleeding index,  probing 
pocket depth, clinical attachment level  of the subjects with chronic periodontitis  
before and 6 weeks after  scaling and root planing. 
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GENERAL REVIEW: 
Chronic periodontitis is primarily an anaerobic gram negative infection of the oral 
cavity, which results in a chronic inflammatory state of the supporting structures of 
the teeth producing an array of symptoms starting with gingival inflammation and 
progressive destruction of the periodontal tissues. The colonization of microflora in 
the periodontal tissues acts on the bone and results in loss of alveolar bone leading 
eventually to exfoliation of teeth. It is hypothesised that there are certain organisms 
that inhabit and constitute the microbial flora of the dental plaque are the major 
etiological agents in the pathogenesis of periodontitis. These microbes, specifically 
Porphyromonas gingivalis produce lipopolysaccharides (LPS) which act as 
endotoxins and bring about an immune response from the host. This response often 
leads to host mediated tissue destruction. Periodontitis is primarily an oral disease that 
remained localized within the periodontium and its effects are observed to be limited 
to the oral tissues that support the teeth. But in the light of new evidence, periodontitis 
has been found to cause numerous effects on the systemic wellbeing of the 
individual
17
.  
The bacteraemia that is subsequent to a chronic periodontal infection and the 
endotoxins that are expressed into the systemic circulation initiate and produce an 
immune response from the host. The inflammatory changes that occur as consequence 
pave the way for manifestation of systemic diseases. Specific virulence factors of the 
pathogenic periodontal microbes can affect atherogenic events. Studies in which 
isolation of periodontal pathogens from atheromatous plaques confirm the impact of 
periodontitis on non-oral tissues. To conclude, the effects of periodontal infection on 
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changes of lipid metabolism have been shown as a potentially inducing factor in 
systemic diseases
8
. 
LIPIDS: 
Lipids in the form of fatty acids, triacylglycerols, fat soluble vitamins and steroids, on 
account of their water insolubility, require a carrier protein for binding and transport 
in the blood plasma. Fatty acids are bound with serum albumin and are carried to the 
muscle, heart and liver from the adipose tissue. The redistribution of lipids in the body 
is thus done by transport through the plasma by formation of large complexes, namely 
the lipoproteins. 
Lipoproteins are complex molecules presenting a central core of lipids that are 
hydrophobic in nature. The shell is formed from components that ensure that the 
complex, as a whole is hydrophilic so that it may be transported in plasma. It is made 
of phosphatidylglycerols and proteins of which the protein components are 
responsible for solubilisation. They also have cell targeting signals that help in 
specificity during transport
18
. 
Lipoproteins are characterized based on their density. Among these classes, 
lipoproteins with the lowest density are the chylomicrons followed by chylomicron 
remnants. Further down the list are very low density lipoproteins followed by 
intermediate density lipoproteins, low density and finally the high density lipoproteins 
respectively. The relative amount of lipids with respect to the protein content 
determines the density of the molecule complex. If the protein content is high, the 
overall density is higher. 
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 The apoproteins play vital roles in transport of lipids and their metabolism. Specific 
domains on their structure are recognized by receptors on the surface of cells. 
Amphipathic α-helixes are present as a characteristic feature of these apoproteins 
which have hydrophobic and hydrophilic side chains. The hydrophobic chains face 
inwards towards the lipid core and the hydrophilic residues interact with the polar 
groups of phospholipids or with the solvent which is aqueous in nature. During the 
course of lipoprotein metabolism, there are changes in the affinities of apoproteins’ 
surface components. As a result of these changes, there is an observed diffusion of 
apoproteins from one lipoprotein that move and get bound with another. Apoprotein B 
is the only variety found to sustain association with the same lipoprotein during the 
process of metabolism. 
Chylomicrons are lipids derived from diet which target membrane bound lipoprotein 
lipases (LPLs) and bind to them. These are positioned primarily in adipose reserves 
and muscle tissues which are sites that are responsible from the inter conversion of 
triacylglycerols into fatty acids by hydrolysis. These fatty acids are again transported 
into the adipose cell where resynthesis of triacylglycerols using fatty acids as 
substrates, occurs again. This also serves as the storage site for the triacyglycerols
18
. 
The liver manufactures fatty acids and cholesterol, and prepares them for transport in 
the plasma by incorporating them into lipoproteins, predominantly as very low density 
lipids. Thus it could be inferred that low density lipoproteins are the prime carriers of 
cholesterol in plasma that deliver them to a multitude of tissues. An elevated level of 
such circulating class of lipoproteins that redistribute lipids from the centre towards 
the periphery could indicate an elevated risk of lipids being deposited in undesirable 
areas such as coronary blood vessels, positively correlating with an increased 
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incidence of coronary heart disease. This could be explained by the development of 
atherosclerotic plaques resulting in occlusion of blood vessels causing heart attacks 
and strokes. The liver and intestinal cells also produce and secrete High density lipids 
into circulation. HDL contains enzymes that either cause esterification of cholesterol, 
thereby metabolising it; or are capable of playing a role in transfer of such cholesteryl 
esters
18
.These function to trap the excess cholesterol from the periphery and carry it to 
the liver where it can be metabolized into bile salts which are excreted. The HDL 
function causes the inverse relationship of the HDL levels in plasma and the incidence 
of above mentioned coronary heart diseases. 
 
 
 
 
 
 
 
FIGURE 1: LIVER CELL ABSORBING LDL BY ENDOCYTOSIS 
MECHANISM. 
REVIEW OF LITERATURE 
 
10 
 
NON SURGICAL THERAPY: 
Non-surgical periodontal therapy is the initial phase in the control of chronic 
periodontitis which entails subgingival debridement which is supplemented with 
emphasis in the form of instructions given for maintenance of oral hygiene
9
. Smart et 
al. (1990)
19
 proposed the term periodontal debridement to define ‘the light 
overlapping strokes used for instrumenting the root with a sonic or ultrasonic scaler’. 
Nevertheless, the term has become widely used to denote scaling which could be both 
hand or power-driven in nature. The gentle yet thorough subgingival instrumentation 
is directed at the elimination of toxic substances with care taken not to cause over 
instrumentation or removal of cementum intentionally. The ultimate goal of 
debridement is to produce a root surface which would be biologically suitable for a 
healthy attachment by the periodontium.  
Mechanical debridement is usually practised as the initial phase of treatment in most 
periodontal infections
20
. These procedures are targeted at reducing the load of the 
bacterial colonies associated with the periodontal tissues. It also alters the 
composition of the microbial flora into a state more associated with a healthy 
periodontium. Consequentially, the degree of inflammation is lowered and the 
periodontal attachment levels achieve a relative stability
21
.  
Studies have presented results of marked shift in the composition of the microflora 
from samples taken from subgingival pockets after the manual or power 
instrumentation in the form of sonic or ultrasonic scalers. It has also been noted that 
the use of ultrasonics resulted additionally in a reduction in the colonies of motile rods 
and spirochetes
20
. 
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It was observed that merely performing subgingival debridement without ample oral 
hygiene measures resulted in an incomplete healing response from the periodontal 
tissues
9
. 
 
RELATIONSHIP BETWEEN NON-SURGICAL THERAPY AND LIPID 
PROFILE IN CHRONIC PERIODONTITIS:
 
The relationship between periodontitis and cardiovascular disease is well evidenced in 
a great number of studies. Several causal mechanisms were proposed for the cascade 
of events resulting in these systemic effects, including the roles of bacterial 
endotoxins and inflammatory cytokines in atherogenesis. Conclusions of the 
EFP/AAP workshop conducted to analyse this correlation point towards the 
postulation that periodontal therapy resulted in a progressive and consistent reduction 
in the amount of systemic inflammation
22
. Three parameters could be considered 
when evaluating such an influence of periodontal therapy on the lipid profile and thus, 
on the incidence of cardiovascular diseases; namely the inflammatory biomarkers, 
endothelial function, and improvement in metabolic control.  
The levels of C-Reactive protein (hsCRP), IL-6, and TNF-α were shown to be 
elevated in inflammatory states and shown to have a continuous association with the 
risk of coronary heart disease and stroke. It is a customary of cardiologists to resort to 
prescription of statins in achieving the optimal LDL cholesterol levels. Control over 
other risk factors for CVD, such as overweight, smoking may prove to be 
unpredictable in achieving the favourable outcome. It is proposed that a prompt 
screening for periodontal disease in such individuals for the presence of periodontitis 
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and if present, undertaking periodontal therapy would significantly improve the lipid 
profile, reducing the risk for future occurrence of CVD. 
Endothelial function also could be used in the assessment of the atherosclerotic profile 
of an individual. Analysis of the levels of thrombotic fibrinogen biomarkers and the 
overall endothelial function was also observed in determining the prognosis in such 
cases with an increased risk for cardiovascular disease. It was observed that non-
surgical periodontal therapy resulted in s significant improvement in endothelial 
function
23
. This improvement was found to be well sustained even after 6 months 
following therapy and this difference was marked in patients presenting with co-
morbidity such as CVD and diabetes mellitus.  
Another major finding was that periodontal therapy resulted in a notable improvement 
of the metabolic control in periodontitis patients with diabetes. This is demonstrated 
by the reduction in HbA1c levels in clinical trials studying the effect of periodontal 
therapy on metabolic state
24
.  
Low grade systemic inflammation has been established as a risk factor for CVD. In 
this regard, elevated CRP levels, IL-6, TNF-α, fibrinogen, and other metabolic 
biomarkers are strongly associated with increased incidence of coronary heart disease 
and stroke. Periodontal intervention reduced the levels of lipids in the form of 
triglycerides, total cholesterol levels and elevated the levels of HDL, thereby 
improving the lipid profile of patients with CVD.  
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REVIEW OF LITERATURE: 
 
Rabinowitz JL et al 1991
25 
matched the chemical composition and metabolism of 
gingival lipids derived from inflamed and non-inflamed sites. Domesticated cats were 
used in the study as they presented with naturally occurring periodontitis. Chemical 
analysis of lipids from samples of gingival tissue from six domestic cats affected with 
periodontitis revealed no notable differences amongst inflamed and non-inflamed 
tissues. The probability of variation in acetate pool size was also studied and it was 
found that inflamed gingiva had a larger pool of acetate compared to non-inflamed 
gingival tissue in the same case. 
Lösche W et al 2000
26
 measured levels of plasma lipids and fasting blood glucose in 
39 subjects with moderate periodontal disease (age 50–60 years) and 40 control 
subjects who were systemically healthy. Clinical parameters such as probing pocket 
depth, percentage of plaque, bleeding on probing and number of missing teeth were 
recorded. The results were compared between two groups. Although subjects with 
diabetes were excluded from the study, higher blood glucose levels were observed in 
the patient than in the control group; and concluded that total cholesterol, low density 
lipoprotein cholesterol and triglycerides were significantly higher in periodontally 
diseased subjects. Clinical parameters were also higher in the periodontitis group. But 
they were unable to conclude that hyperlipidemia and pre-diabetes may be associated 
with periodontal disease in systemically healthy subjects and whether periodontal 
disease causes an increase in hyperlipidemia in a pre-diabetic state or whether 
periodontal disease and cardiovascular disease share hyperlipidemia and the pre-
diabetic state as common risk factors.  
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Katz J et al 2002
27 
conducted a study based on the hypothesis that periodontal 
pockets may be associated with elevated blood lipid levels - a known risk factor 
atherosclerotic disease, among 10,590 Israeli military service men and women who 
were assessed using the Community Periodontal Index of Treatment Needs (CPITN) 
using flat dental mirrors and CPITN probes according to the WHO protocol (1967). 
The relationship of blood lipids and periodontal disease was also evaluated, along 
with confounding factors that are related to elevated cholesterol levels, including high 
body mass index (BMI), age, diastolic blood pressure and smoking. They concluded 
that the presence of periodontal pockets as measured by CPITN was positively 
associated with higher cholesterol and low density cholesterol (LDL) blood levels in 
men. No significant association was found in women. 
Elter JR et al 2004
28 
undertook a cross sectional study to evaluate the relationship of 
tooth loss and periodontitis to prevalent coronary heart disease at the Atherosclerosis 
Risk in Communities (ARIC) visit using both tooth loss and clinical signs of disease 
in a sample of 8363 men and women aged 52 to 75 years from four United States 
communities. The ARIC clinical examination included anthropometry including body 
mass index, blood pressure. ECG, clinical chemistries, plasma lipids, medications, 
and health questionnaires and the dental ARIC consisted of an oral examination, 
included collection of gingival crevicular fluid (GCF), oral plaque and serum for lipid 
profile and interviews along with probing depth and cemento enamel junction 
measures on six sites for all remaining teeth and concluded that individuals with both 
high attachment loss and high tooth loss and edentulous individuals had elevated odds 
of prevalent coronary heart disease compared to individuals with low attachment loss 
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and low tooth loss, while controlling for a number of traditional risk factors for 
coronary heart disease. 
Doĝan B et al 200529 compared the numbers of cultivable bacteria, composition of 
subgingival microflora and clonal distribution of Actinobacillus 
actinomycetemcomitans in two groups of patients with generalized chronic 
periodontitis (GCP), one with an acute myocardial infarction (AMI-GCP) and the 
other one without AMI (non–AMI-GCP). Clinical parameters such as pocket depth by 
Williams probe, bleeding on probing were measured. Blood samples were taken from 
the 60 patients with AMI. Serum total cholesterol, high density lipoprotein cholesterol 
(HDL-cholesterol), low density lipoprotein cholesterol (LDL-cholesterol), and 
triglyceride concentrations were determined by auto analyzer. Subgingival bacterial 
samples were collected from 11 AMI-GCP and 11 non–AMI-GCP patients. 
Polymerase chain reaction (PCR) technique was used to detect A. 
actinomycetemcomitans and Porphyromonas gingivalis (P. gingivalis) and concluded 
that the mean proportions of P. gingivalis and Tannerella forsythensis (T. 
forsythensis) were significantly lower, but the numbers of Micromonas micros 
(M.micros) and A. actinomycetemcomitans were up to nine times higher and the mean 
total number of cultivable bacteria per sample higher in AMI-GCP than in non–AMI-
GCP. Lipid profile was found to be unaltered. 
Tuter G et al 2007
16
 studied thirty-six patients randomly distributed into two groups: 
Placebo or subantimicrobial dose doxycycline for 6 weeks who also received two 
regimens of scaling and root planing. At baseline and 6 weeks, gingival crevicular 
fluid and blood were collected and clinical indices were recorded. Between groups, 
there were statistically significant greater improvements in pocket depth, gingival 
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index, apolipoprotein-A and high density lipoprotein cholesterol levels, favouring the 
group receiving sub-antimicrobial dose doxycycline adjunctive to scaling and root 
planing. 
Rufail ML et al 2007
30
 reported that certain types of chronic infections can increase 
the plasma level of very low density lipoprotein, leading to formation of the 
particularly atherogenic low density lipoprotein subclass, small dense low density 
lipoprotein. In their study, they examined whether aggressive forms of periodontitis 
are associated with these atherogenic lipoprotein parameters. Twelve healthy control 
subjects without periodontitis, 12 subjects with localized aggressive periodontitis and 
12 subjects with generalized aggressive periodontitis were studied. Lipoprotein 
subclass levels were determined using nuclear magnetic resonance methodology and 
it was concluded that healthy control subjects, localized aggressive periodontitis 
subjects and generalized aggressive periodontitis subjects had progressively higher 
plasma levels of very low density lipoprotein and progressively smaller average low 
density lipoprotein size. After adjustment for body mass index, the mean periodontal 
pocket depth correlated positively with plasma very low density lipoprotein levels. 
Very low density lipoprotein concentrations correlated positively with small dense 
low density lipoprotein levels and negatively with average low density lipoprotein 
size. Prevalence of the atherogenic lipoprotein pattern B in healthy controls, localized 
aggressive periodontitis subjects and generalized aggressive periodontitis subjects was 
8.3%, 33.3% and 66.6%, respectively. 
Sblendorio V , Palmieri B 2008
31
 reported that total cholesterol (TC) and low 
density lipoprotein cholesterol (LDL-C) levels were positively related to coronary 
heart disease (CHD), and high density lipoprotein cholesterol (HDL-C) levels were 
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negatively related to CHD by screening approximately 375 adults, aged 18years and 
above. All subjects fasted for 12-14 hours, and venous blood was collected under 
standardized conditions between 08:00 and 10:00 and the EDTA blood samples were 
tested using the CR3000 system and the above positive correlation was reported. 
Goteiner D et al 2008
32 
 reported an association between poor dental health and acute 
coronary syndrome (ACS) and correlated the presence of periodontitis with serum 
endotoxin/lipopolysaccharides (LPS), lipid profiles, troponin, and immunoglobulin G 
(IgG) antibody to Porphyromonas gingivalis in control patients or patients with ACS 
or angina at the time of hospital admission. Blood samples from 194 subjects 
presenting with ACS, angina, or non-cardiac chest pain were analyzed for endotoxin / 
LPS (Limulus amebocyte lysate assay), lipid profile, troponin, and IgG antibody to P. 
gingivalis. Data was collected from hospital charts and dental records, and health 
questionnaire responses and they concluded that subjects with ACS or angina were 
more likely to have poor oral care, fewer remaining teeth, and increased alveolar 
radiographic bone loss compared to subjects with chest pain. In all subjects, 
endotoxin/ LPS and IgG antibody to P. gingivalis tended to increase in association 
with increased radiographic bone loss. Endotoxin/LPS increased directly with 
triglyceride and troponin levels and inversely with high density lipoprotein (HDL) 
levels. IgG antibody to P. gingivalis levels was directly correlated with very low 
density lipoprotein and triglycerides and inversely with low density lipoprotein. 
Saxlin T et al 2008
33 
investigated the association between serum lipids and 
periodontal infection and the role of serum lipids in the association between body 
weight and periodontal infection, in 8028 subjects aged 30 or older living in 
continental Finland and the study was based on a subpopulation of dentate, non-
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diabetic subjects who had never smoked and were aged under 50 years. Periodontal 
infection was defined as the presence of teeth with deepened periodontal pockets. 
Serum levels of triglycerides, high density lipoprotein (HDL) and low density 
lipoprotein (LDL) were analysed enzymatically and it was concluded that there was 
no consistent association between serum lipid levels and periodontal infection among 
normoweight subjects. There was an association of high serum triglycerides and low 
HDL with periodontal infection among obese subjects. The association between body 
mass index and periodontal infection was not essentially affected by serum lipids.  
Fentoğlu Ö et al 20095 in their study evaluated fifty-one subjects with hyperlipidemia 
and 47 normolipidemic subjects. Biochemical parameters, including plasma 
triglyceride, total cholesterol, low density lipoprotein cholesterol, high density 
lipoprotein cholesterol levels and periodontal parameters, were assessed. Results of 
study showed that patients with mild or moderate hyperlipidemia manifested higher 
values of periodontal parameters namely, plaque index, probing pocket depth, clinical 
attachment level, bleeding on probing % compared to normolipidemic individuals. 
Monteiro AM et al 2009
7 
evaluated forty patients with periodontitis and forty healthy 
individuals by measuring total cholesterol, high density lipoprotein, low density 
lipoprotein, levels of cytokines, antibodies against oxidized low density lipoprotein, 
thiobarbituric acid reactive substances, total and differential white blood cell counts. 
The levels of triglyceride and high density lipoprotein in periodontitis patients were 
significantly higher and lower respectively, compared to controls. 
Sridhar R et al 2009
34 
studied a total of 120 subjects with 30 subjects in each of the 
following groups: healthy group (A), chronic periodontitis group (B), coronary heart 
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disease (CHD + periodontitis group) (C) and periodontitis group (D). All subjects 
underwent oral examination and their gingival index, oral hygiene index, periodontal 
disease index scores and attachment loss were recorded. Two millilitres of fasting 
venous blood sample was drawn and tested for the level of total cholesterol, low 
density lipoprotein (LDL), high density lipoprotein (HDL) and triglyceride level and 
it was concluded that there was no significant difference with respect to the lipid 
profile levels between the four groups. Interpreting the results of their study, it was 
inferred that periodontal disease did not cause an increase in total CHL, LDL or 
triglyceride levels or a decrease in the HDL levels in an otherwise systemically 
healthy individual or in a CHD patient. Periodontitis in a CHD patient did not seem to 
exacerbate the destruction of periodontal tissue and higher triglyceride levels did not 
have any correlation with the severity of attachment loss in a periodontitis subject. 
Fentoğlu Ö et al 20113 evaluated serum and gingival crevicular fluid (GCF) pro-
inflammatory cytokine levels in association between periodontal disease and 
hyperlipidaemia. They examined 123 subjects with hyperlipidaemia and among them 
68 patients were systemically healthy who were included as control groups. 
Hyperlipidaemic groups were divided into two groups as suggested diet (HD) and 
prescribed statin (HS). Both groups were divided into three subgroups as healthy (h), 
gingivitis (g) and periodontitis (p). The clinical periodontal parameters, fasting venous 
blood and GCF samples were obtained, and serum tumour necrosis factor-alpha 
(TNF-α, interleukin (IL)-1β (IL-1β) and IL-6 levels were evaluated and resulted that 
ratio of total cholesterol to high-density lipoprotein (TC/HDL) was associated with 
gingival index and percentage of bleeding on probing (BOP%) in both 
hyperlipidaemic groups. In HS group, GCF and serum IL-6 were positively correlated 
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with BOP% and TC/HDL. GCF TNF-α was positively associated with probing pocket 
depth and clinical attachment level, whereas serum TNF-α was associated with 
BOP% in the HD group. Serum and GCF TNF- α and IL-1β were significantly 
associated with TC/HDL in the HD group. 
Fentoğlu Ö et al 201135 evaluated the levels of serum lipoprotein-associated 
phospholipase A2 (Lp-PLA2) and high sensitivity C-reactive protein (hsCRP) in 
association with periodontal disease and hyperlipidemia from 123 subjects with 
hyperlipidemia and 68 systemically healthy controls. Subjects with hyperlipidemia 
were divided into two groups: the suggested-diet (HD) and prescribed statin (HS) 
groups and then into three subgroups: the healthy (HDh and HSh), gingivitis (HDg 
and HSg), and periodontitis (HDp and HSp) groups. Periodontal parameters were 
recorded, which included the plaque index (PI), gingival index (GI), probing depth 
(PD), clinical attachment level (CAL), and percentage of sites with bleeding on 
probing (BOP). Fasting venous blood samples were obtained, and serum lipid, Lp-
PLA2, and hsCRP levels were evaluated and concluded that median values for the GI, 
PD, BOP(%), and CAL in the HSg group were statistically significantly higher than 
those in the HDg and systemically healthy with gingivitis (Cg) groups. The HSp 
group had higher percentages of BOP compared to those of the chronic periodontitis 
and HDp groups. The HDg group had higher serum Lp-PLA2 and hsCRP levels 
compared to those of the Cg and HSg groups. The ratio of total cholesterol to high-
density lipoprotein cholesterol (TC/HDL) was significantly associated with the GI, 
PD, and BOP (%) in both groups with hyperlipidemia. Serum Lp-PLA2 and hsCRP 
levels were significantly correlated with TC/HDL, the GI, PD and BOP (%) in the HD 
group. 
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Vieira CL et al 2011
36 
conducted a pilot study, which evaluated the association of 
severe periodontitis with pulse wave velocity (PWV), carotid artery intima-medial 
thickness (IMT), and clinical, metabolic, and atherogenic inflammatory markers in 79 
subjects with heterozygous familial hypercholesterolemia (hFH). All subjects were 
free of previous vascular disease manifestations. Parameters evaluated were the body 
mass index (in kilograms per square meter), plasma lipids, glucose, C-reactive 
protein, and white blood cell counts and full mouth periodontal examinations were 
also conducted and they were categorized into the severe periodontitis group (SPG) or 
non-severe periodontitis group (NSPG) and finally concluded that SPG showed 
significantly higher values of cholesterol-year scores, triglycerides, glucose, PWV, 
IMT, and diastolic blood pressure (DBP) than the NSPG. 
Korhonen S et al 2011
37 
conducted a cross sectional study to investigate whether 
serum total cholesterol/high density lipoprotein cholesterol (TC/HDL) ratio and low 
density lipoprotein cholesterol/high density lipoprotein cholesterol (LDL/HDL) ratio 
were associated with periodontal infection. This study was based on a subpopulation 
of the Health 2000 Survey, which included dentate, non-diabetic subjects who had 
never smoked and who were aged between 30 and 49 years. The numbers of teeth 
with deepened (4mm deep or deeper) and with deep (6mm deep or deeper) 
periodontal pockets and gingival bleeding was used as outcome variables and they 
reported that no consistent associations were evident between TC/HDL or LDL/HDL 
ratios and the number of teeth with deepened periodontal pockets or the presence of 
gingival bleeding among normal weight subjects as well as whose body mass index 
was 25 or more than 25. 
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Sangwan A et al 2013
6 
evaluated the association between serum lipids and 
periodontal disease in patients with chronic periodontitis with limited data available 
regarding periodontal status of patients with hyperlipidemia. In this cross-sectional 
study, 94 patients with hyperlipidemia (50 receiving statins and 44 receiving non 
pharmacologic therapy) and 46 control individuals who were normolipidemic 
underwent periodontal examination. Biochemical parameters measured included 
serum triglyceride, total cholesterol, low-density lipoprotein cholesterol, and high-
density lipoprotein cholesterol levels. The results showed that probing depth and 
gingival index were significantly higher in patients with hyperlipidemia who were 
non-statin users compared with the normolipidemic individuals. 
Lee JB et al 2013
38 
conducted a study to examine whether dyslipidemia was 
associated with periodontitis in a representative sample of Korean adults who were 
involved in the Fourth Korea National Health and Nutrition Examination Survey 
(KNHANES). They examined a total of 18,210 subjects over 19 years of age. The 
periodontal status of the patients was assessed by the Community Periodontal Index 
(CPI). Multivariate logistic regression analysis was carried out. In their analysis, 
periodontitis was found to be significantly associated with hypo HDL cholesterolemia 
and had a potential association with hyper triglycerides (TG) in subjects younger than 
40 years. 
Flores MF et al 2014
39
 conducted a cross sectional study and assessed the association 
between periodontal inflammation and tissue breakdown to levels of C-reactive 
protein (CRP) and lipids in patients with stable heart disease from 93 patients with 
stable coronary artery disease who were in outpatient care for at least 6months. After 
applying a structured questionnaire, periodontal parameters like probing pocket depth, 
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clinical attachment level, bleeding on probing were examined. Blood samples were 
collected from patients on the day of periodontal examination to determine levels of 
CRP, lipids, and glycated haemoglobin in cases that presented high levels of 
periodontal inflammation and tissue breakdown. The concentrations of triglycerides 
(TGs), very low density lipoprotein cholesterol, and glucose were significantly higher 
in individuals with severe periodontitis and clinical attachment loss ≥6 mm and 
presence of severe periodontitis was significantly associated with higher CRP 
concentrations. Bleeding on probing was significantly associated with TGs, total 
cholesterol, and non-high density lipoprotein cholesterol. 
Fentoğlu Ö et al 201540 determined the serum levels of malondialdehyde (MDA), as 
a lipid peroxidation marker, and 8-hydroxydeoxyguanosine (8-OHdG), as an 
oxidative DNA damage marker, in patients with chronic periodontitis (CP) and 
hyperlipidemia. They selected a total of 74 individuals who were divided into four age 
and sex matched groups, 18 patients with hyperlipidemia and CP (HLp), 18 
periodontally healthy patients with hyperlipidemia (HLh), 19 systemically healthy 
individuals with CP (Cp), and 19 systemically and periodontally healthy controls 
(Ch). Clinical periodontal parameters such as probing pocket depth, clinical 
attachment level, bleeding on probing, plaque index, gingival index and serum lipids, 
MDA, and 8-OHdG levels were assessed in blood samples and concluded that 8-
OHdG, MDA, probing depth, clinical attachment level, and percentage of sites 
bleeding on probing (BOP) were significantly higher in the HLp group than the Cp 
group. A significant correlation between 8-OHdG and MDA was also observed in the 
hyperlipidemia group. 
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Lal V et al 2015
1 
studied the relation between serum lipid profile and periodontitis. 
The levels of serum lipid profile in 60 subjects, 30 with chronic generalized 
periodontitis based on clinical attachment loss constituting the test group and 30 
without periodontitis constituting the control group, were measured and compared 
with each other. Results showed that high serum cholesterol and total cholesterol may 
be associated with periodontitis in otherwise healthy people. 
Gao H et al 2015
41 
evaluated the association of low density lipoprotein receptor 
related protein 5 (LRP5) and apolipoprotein E (APOE) polymorphisms with serum 
lipid concentrations and generalized aggressive periodontitis within a Chinese 
population. Mean serum lipid concentrations were compared across LRP5 and APOE 
polymorphisms and it was found that individuals with generalized aggressive 
periodontitis exhibited significantly lower serum total cholesterol (TC) and lower high 
density lipoprotein cholesterol (HDL-c). Individuals with LRP5 polymorphisms 
(rs682429-AA or rs312016-GG) exhibited higher TC, higher HDL-c levels. 
Furthermore, individuals with the combined polymorphisms (LRP5-rs682429-AA and 
APOE-rs429358-CC/CT) had higher levels of low density lipoprotein cholesterol, 
higher levels of TC. 
Hada DS et al 2015
42 
evaluated the effect of nonsurgical periodontal treatment 
(NSPT) on the cardiovascular clinical and biochemical status of coronary heart 
disease (CHD) patients from 70 known CHD patients who were randomly allocated to 
control group (C) (no periodontal therapy) and experimental group (E)(non-surgical 
periodontal treatment in the form of scaling and root planing/ SRP). Cardiovascular 
status was assessed using clinical parameters like pulse, respiratory rate, blood 
pressure (BP) and biochemical parameters like high sensitive C-reactive protein 
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(hsCRP), lipid profile and WBC count at baseline, 1, 3, and 6 months and concluded 
that highly statistically significant reduction was observed in systolic BP (7.1 mmHg), 
and very low density lipoproteins (VLDL) (5.16 mgm/dl) in the group E. 
Nibali L et al 2015
43
 evaluated the lipid and oxidative stress profiles in patients with 
aggressive periodontitis (AgP), and related those to clinical variables and interleukin 
(IL-6) genetic variants among twelve non-smoking Caucasian patients with AgP 
selected based on their IL6 haplotypes who underwent periodontal non-surgical and 
surgical treatment. Peripheral blood samples were collected at baseline and at six 
different time-points after treatment and were processed to determine IL-6 circulating 
levels, lipid profiles (cholesterol, triglycerides, high-density lipoprotein [HDL] and 
low-density lipoprotein [LDL] subclasses) and oxidative stress markers (glutathione 
and total lipid hydroperoxide levels) and concluded that the lipid profile did not 
consistently change after treatment up to 3 months after surgery. 
Kırzıoğlu FY et al 201644 investigated the effects of 2% cholesterol-enriched diet on 
alveolar bone loss (ABL)and serum levels of pro-oxidants and antioxidant enzymes in 
rats with experimental periodontitis which were randomized into four following 
groups: 1) group C (standard diet/periodontally healthy); 2) group Hc (high-
cholesterol diet); 3) group HcP (high-cholesterol diet/periodontitis); and 4) group P 
(standard diet/periodontitis).All rats were fed for 8 weeks. At 6 weeks, experimental 
periodontitis was induced. At the end of week 8, the rats were sacrificed. 
Histomorphometric and histopathologic analyses were performed. Malondialdehyde 
(MDA), nitric oxide (NO), superoxide dismutase, and glutathione peroxidase (GPX) 
levels in serum were measured with enzyme-linked immunosorbent assay and resulted 
that the experimental groups exhibited increases in total cholesterol, low-density 
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lipoprotein, and high-density lipoprotein compared to group C. The cholesterol-
enriched diet induced ABL in group Hc; groups HcP and P had more extensive ABL. 
Sayar F et al 2016
45 
conducted a cross-sectional study on 90 participants including 30 
individuals with a normal lipid profile (group H), 30 hypertriglyceridemic patients not 
on medication (group N) and 30 hypertriglyceridemic patients taking gemfibrozil over 
a three month period (group M). Periodontal parameters including probing depth 
(PD), clinical attachment level (CAL), bleeding on probing (BOP) and plaque index 
(PI) were measured at four sites of each tooth. Serum levels of total cholesterol (TC), 
TG, low density lipoprotein (LDL) and high-density lipoprotein (HDL) were 
measured and concluded that the mean values for PD and CAL in the two 
hypertriglyceridemic groups were significantly higher than those of the H group. 
Thapa S, Wei F et al 2016
46 
evaluated high serum total cholesterol (STC) in a total of 
1,061 participants from the 2011 to2012 National Health and Nutrition Examination 
Survey who underwent both periodontal examination and laboratory test for STC and 
observed that participants with higher STC were more likely to have periodontitis 
compared to those with normal levels. 
Joo JY et al 2017
47
 evaluated the ability of peptide 19 (Pep19) of Porphyromonas 
gingivalis(P. gingivalis) heat shock protein (HSP) as a potent inducer of LDL 
oxidation, with a secondary objective to compare this ability with that of Pep19 from 
different bacteria and concluded that Monocyte-mediated native-LDL oxidation under 
the influence of Pep19 or HSP60 from P. gingivalis was significantly stronger than 
the oxidation induced by the counterpart Pep19 or HSP60 from C. pneumoniae or M. 
tuberculosis. Pep19 from P. gingivalis HSP60 showed a stronger ability to induce 
REVIEW OF LITERATURE 
 
27 
 
LDL oxidation than did Pep14 from P. gingivalis HSP60 which suggested that Pep19 
from P. gingivalis HSP60 has a distinct ability to induce native-LDL oxidation as a 
plausible mechanism by which this peptide may drive epitope spreading to the 
neoantigen, i.e., oxidized LDL, in the pathogenesis of atherosclerosis. 
Haro A et al 2017
48
 conducted a study based on a subpopulation of the Health 2000 
Survey that included 878 subjects who were aged between 45 and 64 years, dentate, 
non-diabetic and non-rheumatic. The inflammatory condition of periodontium was 
measured by means of the number of teeth with deepened (4 mm or deeper) 
periodontal pockets. Systemic inflammation was assessed by means of the serum 
levels of interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α). The number 
of teeth with deepened periodontal pockets was associated with elevated serum IL-6 
levels among subjects with an unfavourable lipid composition (low-density 
lipoprotein cholesterol ≥ 3.7 mmol/l or high-density lipoprotein cholesterol < 1.3 
mmol/l). There was no association between serum TNF-α levels and the number of 
teeth with deepened periodontal pockets in these data. 
Liljestrand JM et al 2017
49
 studied the association of lipopolysaccharide in saliva 
and serum with each other, periodontal microbial burden, periodontitis and coronary 
artery disease. The subjects were analysed under three groups: no significant coronary 
artery disease (n = 123), stable coronary artery disease (n = 184) and acute coronary 
syndrome (n = 169). Periodontitis was defined according to clinical and radiographic 
examinations. Levels for 75 strains of subgingival bacteria were determined by 
checkerboard DNA-DNA hybridization. Saliva and serum lipopolysaccharide activity 
was analyzed by Limulus amebocyte lysate assay and it was concluded that in patients 
with periodontitis, the subgingival microbial burden contributed to endotoxemia and 
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Lipopolysaccharide was a possible molecular mediator between periodontitis and 
coronary artery disease. 
Punj A and Shenoy SB 2017
50
 estimated and compared the endothelial function via 
flow mediated dilation (FMD) assessment in periodontal health and disease. A total of 
120 patients were selected and categorized equally into three groups of healthy, 
chronic periodontitis and myocardial infarction patients. Periodontal inflamed surface 
area (PISA) was assessed in all patients. Fasting blood samples were collected to 
estimate lipid profile. Lipid profile levels were statistically significant on comparison 
between healthy and chronic periodontitis and between chronic periodontitis and 
myocardial infarction group and it was concluded that the endothelial function was 
impaired in chronic periodontitis patients when compared to the healthy controls and 
the dysfunction observed was similar to that observed in myocardial infarction group 
based on the FMD values. 
Lee S, Im A, Burm E, Ha M 2017
51
 examined the association between blood lipid 
profile and periodontitis. The study included 6,905 Korean adults, aged ≥20 years. 
Individuals with complete data on blood lipid levels and those who had the results of 
periodontitis examined by using the Community Periodontal Index system in the Fifth 
Korean National Health and Nutrition Examination Survey for 2010 and 2012 were 
included in the study and it was concluded that women with low HDL cholesterol 
levels showed significantly higher risk of periodontitis and those with high LDL 
cholesterol levels showed higher risk of the disease than those with high HDL and 
low LDL levels. There was a significant association between periodontitis and low 
HDL and high LDL cholesterol levels in women. 
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MATERIALS AND METHODS: 
PATIENT SELECTION: 
The patients who participated in the study were selected from out-patients who visited 
the Department of Periodontology, Best Dental Science College & hospital, Madurai. 
A total of 31 patients including both males and females aged between 30-60 years 
were selected. The study subjects were clinically (using UNC-15 probe) and 
biochemically (lipid profile) evaluated. 
The study protocol was approved by the Institutional Ethical Committee and 
Review Board (27.09.2016). Written and verbal consent was obtained from the 
selected patients. All the patients included in the study satisfied the following 
inclusion and exclusion criteria. 
INCLUSION CRITERIA: 
1. Age between 30-60 years (both males and females). 
2. Minimal presence of 16 natural teeth other than third molars.  
3. Patients with chronic periodontitis having probing pocket depth of more than  
5 mm and more than 10 sites.  
4. Systemically healthy patients. 
EXCLUSION CRITERIA: 
1. History of Periodontal therapy before 3 months. 
2. Pregnancy, lactation or hormone replacement therapy at the time of study. 
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3. Bisphosphonate treatment or use of any other drug known to alter bone 
calcium metabolism. 
4. Patients who had received anti-microbial, anti-inflammatory, immune 
suppressors, statins. 
5. Patients with history of smoking and alcoholism. 
RANDOMIZATION: 
31 patients were randomly selected using a completely randomized design. 
ARMAMENTARIA: 
ARMAMENTARIUM FOR CLINICAL EVALUATION: 
1. Mouth mirror. 
2. Explorer. 
3. UNC- 15 periodontal probe. 
ARMAMENTARIUM FOR LIPID EVALUATION: 
1. 2 ml Syringe. 
2. Vacutainer (Red colour). 
NON SURGICAL ARMAMENTARIUM: 
1. Sterile surgical gloves. 
2. Mouth mirror. 
3. UNC-15 periodontal probe. 
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4. Explorer. 
5. Cotton pliers. 
6. Sterilized cotton pellets and gauze. 
7. Povidine iodine (0.5%). 
8. 2ml Syringe. 
9. Universal Gracey curettes. 
10. Area specific Gracey curettes. 
11. Cumine scaler. 
12. 2% lignocaine local anesthetic agent containing adrenaline in the ratio of 
1:80,000. 
13. Normal saline. 
LIPID PROFILE EVALUATION: 
At the baseline and six weeks appointments, a fasting (8 hours) blood draw was taken 
before conducting the dental procedures. 2ml of intravenous blood was collected 
using sterile syringe from the patients antecubital vein and transferred into 
vacutainer
52
 and sent to laboratory for complete lipid profile analysis, that is total 
cholesterol, triglyceride, high density cholesterol, low density cholesterol, very low 
density cholesterol levels. 
 CLINICAL PARAMETERS 
1. Plaque Index (Modification by Loe 1967)
53
 
2. Gingival Index (Modification by Loe 1967)
53
 
3. Sulcular Bleeding Index (Muhlemann HR & Son S 1971)
54 
4. Probing pocket depth.
55
 
MATERIALS AND METHODS 
 
32 
 
5. Clinical attachment level.
55
 
PLAQUE INDEX: 
Plaque index was described by Silness and Loe in 1964 and modified by Loe in 
1967
53
. The scores and the interpretation of the plaque index are given below. 
Score Criteria 
0 No plaque 
1 A film of plaque adhering to the free gingival margin and adjacent area of the 
tooth. The plaque may be seen only by running a probe across the tooth 
surface. 
2 Moderate accumulation of soft deposits within the gingival pocket, on the 
gingival margin and/or adjacent tooth surface, which can be seen by the 
naked eye. 
3 Abundance of soft matter within the gingival pocket and/or on the gingival 
margin and adjacent tooth surface 
Calculation of Plaque Index: 
Plaque index for the area: Each area (disto-facial, mesio-facial, facial and lingual) is 
assigned a score from 0-3. 
Plaque index for a tooth: The scores from the four areas are calculated and divided by 
four. 
Plaque index score for the individual: The scores for each tooth were added and then 
divided by the total number of teeth examined. 
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INTERPRETATION: 
Excellent 0 
Good 0.1-0.9 
Fair 1.0-1.9 
Poor 2.0-3.0 
 GINGIVAL INDEX: 
The Gingival Index (GI) was developed by Loe and Silness in 1963 and modified by 
Loe in 1967
53
. 
Instrument used: Mouth mirror and periodontal probe. 
The tissues surrounding each tooth are divided into four gingival scoring units: 
distofacial papilla, facial margin, mesio-facial papilla and the entire lingual gingival 
margin. The teeth and gingiva should be dried lightly with a blast of air and /or cotton 
rolls. 
Each of the 4 gingival units was assessed according to the criteria as follows: 
Score Criteria 
0 Absence of inflammation/normal gingiva. 
1 Mild inflammation: slight change in color, slight edema; no bleeding on 
probing 
2 Moderate inflammation: moderate glazing, redness, edema and 
hypertrophy, bleeding on probing. 
3 Severe inflammation: marked redness and hypertrophy, ulceration, 
tendency to spontaneous bleeding. 
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 Calculation of Gingival index: 
Gingival index Score for the area: Each area (disto-facial, facial, mesio-facial, lingual) 
is assigned a score from 0 to 3. 
Gingival index Score for a tooth: The scores from the four areas of the tooth are added 
and then divided by four. 
Gingival index score for the individual: The indices for each of the teeth are added 
and then divided by the total number of teeth examined. The scores range from 0 to 3. 
INTERPRETATION: 
Gingival scores Condition 
0.1-1.0 Mild Gingivitis 
1.1-2.0 Moderate Gingivitis 
2.1-3.0 Severe Gingivitis 
SULCULAR BLEEDING INDEX: 
It was developed by Muhlemann HR and Son S 1971
54
.  
Score Criteria 
0 Healthy appearance of P and M, no bleeding 
upon probing 
1 Bleeding on probing, no color change, no 
swelling of P and M 
2 Bleeding on probing, change in color, no 
swelling of P and M 
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3 Bleeding on probing, change in color, slight 
swelling of P and M 
4 Bleeding on probing, change in color, 
obvious swelling of P and M 
5 Spontaneous Bleeding on probing, change in 
color, marked swelling of P and M 
Calculation of Sulcular Bleeding Index: 
Each of the four units (M and P) is scored from 0-5.  
The scores are totalled and divided by four to obtain the SBI for the tooth.  
By totalling the scores for individual teeth and dividing the number of teeth individual 
SBI score is determined. 
PROBING POCKET DEPTH
55
: 
Probing pocket depth was measured using a UNC-15 periodontal probe in the mid 
buccal on mid lingual area with the fabricated stent in place.
 
CLINICAL ATTACHMENT LEVEL
55
: 
Clinical attachment level is the distance between the base of the pocket and a fixed 
point on the crown, such as the cementoenamel (CEJ) junction. 
When the gingival margin is located on the anatomic crown the level of attachment is 
determined by subtracting from the depth of the pocket the distance from the gingival 
margin to the CEJ. If both are same, the loss of attachment is zero. 
When the gingival margin coincides with the CEJ, the loss of attachment equals the 
pocket depth. 
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When the gingival margin is located apical to the CEJ, the loss of attachment is 
greater than the pocket depth and therefore the distance between the CEJ and the 
gingival margin is added to the pocket depth. 
 
SCALING AND ROOT PLANING: 
After the baseline clinical recordings and blood sampling, phase-I therapy was 
performed proceeding with scaling and root planing. Intraoral and extraoral antisepsis 
was maintained using povidine iodine. After administrating local anesthesia (2% 
lignocaine in the ratio of 1:80,000) and achieving proper anesthesia, full mouth 
scaling and root planing was performed once a week for 2 weeks by sharp sickles, 
gracey and universal curettes and ultrasonic instruments. Oral hygiene maintenance 
was reinforced to all the patients. All the clinical measurements and lipid profile 
examination were repeated 6 weeks after scaling and root planing. 
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FIG.2: ARMAMENTARIUM FOR CLINICAL EVALUATION 
 
 
FIG.3: ARMAMENTARIUM FOR LIPID EVALUATION 
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FIG.4: ARMAMENTARIUM FOR SCALING AND ROOT PLANING 
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Fig.5: PHLEBOTOMY PROCEDURE 
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Fig.6: SCALING AND ROOT PLANING PROCEDURE 
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ROOT PLANING PROCEDURE POST OPERATIVE VIEW 
POST OPERATIVE PROBING 
POCKET DEPTH (UNC 15) 
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STATISTICAL ANALYSIS: 
All the clinical and lipid parameters recorded were subjected to the following 
statistical analysis: 
Descriptive analysis that included mean, standard deviation was used for analysis. 
1. Paired ‘t’ test was performed to compare clinical parameters and lipid profile 
changes before and six weeks after scaling and root planing. 
A ‘p’ value of 0.05 or less was considered for statistical significance. 
Minimum age of the patient was 30 years and maximum was 57 years. The mean age 
of the sample was 40.26 years with standard deviation of 7.03 years 
Gender distribution of the 31 patients was as follows: There were 21 males and 10 
females.   
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RESULTS: 
The present clinical study was conducted to estimate and compare the levels of lipid 
profile in patients presenting with chronic periodontitis before and after scaling and 
root planing.  
A total of 31 patients satisfying the selection criteria were selected. Clinical 
parameters, namely the plaque index, gingival index, sulcular bleeding index, probing 
pocket depth and clinical attachment level of the subjects were recorded. Lipid 
profiles of the patients were also estimated pre operatively. Scaling and root planing 
was done and the same values were recorded 6 weeks following the non-surgical 
therapy. 
CLINICAL PARAMETERS: 
Plaque Index: (Table 1 & Graph 1) 
The mean plaque index score at baseline was 1.68 ± 0.32 which was reduced to 0.38 ± 
0.12 at 6 weeks showing a mean reduction of 1.30 ± 0.28 at 6 weeks, which was 
statistically highly significant with the p value of 0.000 (p ˂0.05). 
Gingival Index: (Table 2 & Graph 1) 
The mean Gingival Index score at baseline was 1.73 ± 0.31 which was reduced to 
0.42 ± 0.14 at 6 weeks showing a mean reduction of 1.32 ± 0.30 at 6 weeks, which 
was statistically highly significant with the p value of 0.000 (p ˂0.05). 
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Sulcular Bleeding Index: (Table 3 & Graph 1) 
The mean Sulcular Bleeding Index score at baseline was 2.03 ± 0.43 which was 
reduced to 0.65 ± 0.38 at 6 weeks showing a mean reduction of 1.38 ± 0.50  at 6 
weeks, which was statistically highly significant with the p value of 0.000 (p ˂0.05). 
Probing pocket depth (in mm): (Table 4 & Graph 2) 
The mean Probing pocket depth at baseline was 4.18 ± 1.13 which was reduced to 
3.24 ± 0.53 at 6 weeks showing a mean reduction of 0.93 ± 0.81 at 6 weeks, which 
was statistically highly significant with the p value of 0.000 (p ˂0.05). 
Clinical attachment level (in mm): (Table 5 & Graph 2) 
The mean Clinical attachment level at baseline was 4.55 ± 1.37 which was reduced to 
3.68 ± 0.91 at 6 weeks showing a mean reduction of  0.87 ± 0.62  at 6 weeks, which 
was statistically highly significant with the p value of 0.000 (p ˂0.05). 
LIPID PROFILE PARAMETERS: 
Total cholesterol (in mg/dl): (Table 6 & Graph 3) 
The mean Total cholesterol at baseline was 235.90 ± 57.66 which was reduced to 
196.74 ± 52.30 at 6 weeks showing a mean reduction of 39.16 ± 59.18 at 6 weeks, 
which was statistically highly significant with the p value of 0.001 (p ˂0.05). 
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Triglycerides (in mg/dl): (Table 7 & Graph 3) 
The mean Triglycerides at baseline was 221.71 ± 92.35 which was reduced to 181.32 
± 72.21 at 6 weeks showing a mean reduction of  40.39 ± 82.14 at 6 weeks, which 
was statistically significant with the p value of 0.010 (p ˂ 0.05). 
Low density lipoprotein (in mg/dl): (Table 8 & Graph 3) 
The mean Low density lipoprotein at baseline was 145.52 ± 25.84 which was reduced 
to 121.23 ± 29.38 at 6 weeks showing a mean reduction of  24.29 ±26.60  at 6 weeks, 
which was statistically highly significant with the p value of 0.000 (p ˂0.05). 
Very low density lipoprotein (in mg/dl): (Table 9 & Graph 3) 
The mean Very low density lipoprotein at baseline was 44.95 ± 17.97 which was 
reduced to 33.95 ± 12.25 at 6 weeks showing a mean reduction of 11.00 ±15.16 at 6 
weeks, which was statistically highly significant with the p value of 0.000 (p ˂0.05). 
High density lipoprotein (in mg/dl): (Table 10 & Graph 3) 
The mean High density lipoprotein at baseline was 38.05 ± 6.57 which was increased 
to 43.98 ± 7.52 at 6 weeks showing a mean increase of 5.94 ±8.44 at 6 weeks, which 
was statistically highly significant with the p value of 0.000 (p ˂0.05). 
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CLINICAL PARAMETERS 
TABLE 1: Mean reduction of Plaque Index score from baseline to an interval 
after 6 weeks (in mm). 
Time 
interval 
Mean PI ± 
SD 
Difference 
from 
baseline 
±SD 
95% Confidence 
Interval of the 
difference  
Significance           
(p*) 
Lower Upper 
Baseline 1.68± 0.32      
After  
6 weeks 
 0.38± 0.12    1.30± 0.28 1.20 1.40 26.22      0.000* 
*A p value of 0.000 indicates that the difference is statistically significant. 
 
 
TABLE 2: Mean reduction of Gingival Index score from baseline to an interval 
after 6 weeks (in mm). 
Time 
interval 
Mean GI ± 
SD 
Difference 
from 
baseline ± 
SD 
95% Confidence 
Interval of the 
Difference 
 
Significance 
(p*) 
Lower Upper 
Baseline 1.73± 0.31      
After  
6 weeks 
 0.42± 0.14   1.32± 0.30  1.21 1.43 24.12        0.000* 
*A p value of 0.000 indicates that the difference is statistically significant. 
 
t value 
t value 
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TABLE 3: Mean reduction of Sulcus Bleeding Index from baseline to an interval 
after 6 weeks (in mm). 
Time 
interval 
Mean SBI 
± SD 
Difference 
from 
baseline ± 
SD 
95% 
Confidence 
Interval of the 
Difference  
Significance 
(p*) 
Lower Upper 
Baseline 2.03± 0.43      
After  
6 weeks 
 0.65± 0.38   1.38± 0.50 1.20 1.57 15.22        0.000* 
*A p value of 0.000 indicates that the difference is statistically significant. 
 
GRAPH 1: COMPARISON OF CLINICAL INDICES BETWEEN BASELINE 
AND AFTER 6 WEEKS. 
       
 
t value 
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TABLE 4: Mean reduction of Probing pocket depth from baseline to an interval 
after 6 weeks (in mm). 
Time 
interval 
Mean PD 
± SD 
Difference 
from 
baseline ± 
SD 
95% 
Confidence 
Interval of the 
Difference  
Significance 
(p*) 
Lower Upper 
Baseline  4.18± 1.13      
After  
6 weeks 
 3.24± 0.53  0.93± 0.81 0.63 1.23 6.39        0.000* 
*A p value of 0.000 indicates that the difference is statistically significant. 
 
 
TABLE 5: Mean reduction of Clinical attachment level from baseline to an 
interval after 6 weeks (in mm). 
Time 
interval 
Mean 
CAL ± SD 
Difference 
from 
baseline ± 
SD 
95% 
Confidence 
Interval of the 
Difference   
Significance 
(p*) 
Lower Upper 
Baseline  4.55± 1.37      
After  
6 weeks 
 3.68± 0.91   0.87± 0.62 0.64 1.09 7.79       0.000* 
*A p value of 0.000 indicates that the difference is statistically significant. 
t value 
t value 
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GRAPH 2: COMPARISON OF PPD AND CAL BETWEEN BASELINE AND 
AFTER 6 WEEKS.  
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LIPID PROFILE PARAMETERS: 
TABLE 6: Mean reduction of total cholesterol level from baseline to an interval 
after 6 weeks (in mg/dl). 
Time 
interval 
Mean 
Cholesterol ± 
SD 
Difference 
from 
baseline ± 
SD 
95% Confidence 
Interval of the 
Difference 
 
Significance 
(p*) 
Lower Upper 
Baseline 235.90± 57.66      
After  
6 weeks 
196.74± 52.30 39.16± 59.18 17.45 60.87 3.6 .001 
*A p value of 0.001 indicates that the difference is statistically significant.  
 
TABLE 7: Mean reduction of triglycerides level from baseline to an interval 
after 6 weeks (in mg/dl). 
Time 
interval 
Mean 
Triglycerides 
± SD 
Difference 
from 
baseline ± 
SD 
95% Confidence 
Interval of the 
Difference 
 
Significance 
(p*) 
Lower Upper 
Baseline 221.71± 92.35      
After  
6 weeks 
181.32± 72.21 40.39± 82.14 10.26 70.52 2.74 .010 
*A p value of 0.010 indicates that the difference is statistically significant.  
 
t value 
t value 
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TABLE 8: Mean reduction of LDL level from baseline to an interval after 6 
weeks (in mg/dl). 
Time 
interval 
Mean LDL ± 
SD 
Difference 
from 
baseline ± 
SD 
95% Confidence 
Interval of the 
Difference 
 
Significance 
(p*) 
Lower Upper 
Baseline 145.52± 25.84      
After  
6 weeks 
121.23± 29.38 24.29±26.60 14.68 33.90 5.16 .000 
*A p value of 0.000 indicates that the difference is statistically significant.  
 
TABLE 9: Mean reduction of VLDL level from baseline to an interval after 6 
weeks (in mg/dl). 
Time 
interval 
Mean VLDL 
± SD 
Difference 
from 
baseline ± 
SD 
95% Confidence 
Interval of the 
Difference 
  
Significance 
(p*) 
Lower Upper 
Baseline 44.95± 17.97      
After  
6 weeks 
33.95± 12.25  11.00±15.16 5.44 16.56 4.04 .000 
*A p value of 0.000 indicates that the difference is statistically significant.  
 
 
t value 
t value 
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TABLE 10: Mean increase of HDL level from baseline to an interval after 6 
weeks (in mg/dl)  
Time 
interval 
Mean HDL 
± SD 
Difference 
from 
baseline ± 
SD 
95% Confidence 
Interval of the 
Difference 
  
Significance 
(p*) 
Lower Upper 
Baseline 38.05± 6.57      
After  
6 weeks 
43.98± 7.52   5.94±8.44 9.03 2.84 3.92 .000 
*A p value of 0.000 indicates that the difference is statistically significant.  
 
GRAPH 3: Comparison of Lipid Profile between Baseline and After 6 Weeks.  
 
.00
50.00
100.00
150.00
200.00
250.00
TC TRI LDL VLDL HDL
235.90 
221.71 
145.52 
44.95 
38.05 
196.74 
181.32 
121.23 
33.95 
43.98 
t value 
Baseline After 6 weeks
DISCUSSION 
 
53 
 
DISCUSSION 
Periodontitis is a prevalent presentation of improper oral hygiene leading to 
progressive weakening of the supporting tissues of the natural dentition, where the 
production of pro inflammatory cytokines and tissue degrading enzymes is initiated 
and advanced by oral bacterial infection ultimately resulting in the destruction of the 
periodontal tissue. If unchecked it leads to bone loss, tooth mobility, and gingival 
recession
1
.  
Lipids are a variety of organic molecules that exhibit low water solubility and high 
solubility in non-polar solvents. Basically lipids, being hydrocarbons in nature imply 
that they are highly reduced forms of carbon and hence oxidation and metabolism of 
such molecules in the body yield large amounts of energy. They are of two groups, 
namely – apolar and polar. Apolar consist of trigylcerides stored in various cells but 
especially in adipose tissue which is considered as a main form of energy storage in 
mammals. Polar lipids are principal constituents of cell membranes. They are 
necessary in forming the lipid bilayer which produces a permeability barrier of cells 
and subcellular organelles. Lipids act as essential signalling molecules in various 
biochemical processes in the human body
56
.  
 
One of the predominant etiological factors strongly associated to the pathophysiology 
of CVD can be pointed out as disturbances or alterations in the serum lipid profile. If 
such a rise in the blood concentrations of triglycerides, cholesterol, and low-density 
lipoprotein cholesterol occurs, it may be indicative of the disease. It has also been 
shown that there is a concomitant decrease in the levels of high-density lipoprotein 
cholesterol.  
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Evidence compels us to conclude that Periodontitis is positively associated with 
increased levels of low and very low-density lipoproteins, triglycerides and total 
cholesterol in circulation. This hyperlipidemic state promotes atherosclerotic changes 
of the vessel walls and cause development of cardiovascular changes
57
. A consensus 
report
58
 was published to that effect considering the well-established observations that 
dental infection and cardiovascular diseases not only coexist but are related. It was 
shown that the bacterial entry into blood stream activates a cascade of host 
inflammatory response by different mechanisms and that the host immune response 
helps atheromatous change. Time and again, studies have confirmed these 
observations that the inflammatory changes secondary to periodontal infection and the 
systemic effects may the inciting mechanism of cardiovascular problems
59
.  
Increasing literacy and healthcare awareness has made screening, diagnosis and 
treatment of lipid disorders widely accepted. Furthermore in people with lifestyle and 
dietary habits posing high risk for future CHD, this detection has become 
commonplace in contemporary medical practice. Statins are drugs which are 
frequently used as one of the first line of choice in rectification of such 
hyperlipidemic states. But there is evidence of rhabdomyolysis, Type II Diabetes, 
liver failure, on chronic use
60,61,62 
despite its positive effects on the osteoprotegrin 
levels. Thus it becomes essential to delineate the cause of hyperlipidemia and address 
the etiology instead of a symptomatic approach to treatment which may complicate 
the disease to be treated by numerous dose related adverse effects over long term. 
Based on the undeniable evidence, it is rational to treat the etiology of chronic 
periodontitis at the outset. Calculus removal takes precedence and it is achieved 
through hand instrumentation or ultrasonic instrumentation. It is seen that by the end 
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of this preliminary phase of therapy, there is a marked clinical improvement of oral 
health in patients that presented with advanced periodontitis.  
Non-surgical therapy employs a multitude of procedures that focus primarily on 
elimination of plaque, calculus, necrotic tissue adherent on the root surface and 
periodontal pockets. Mechanical debridement procedure consists of scaling and root 
planing and is a very essential part of the treatment of periodontal diseases. Scaling 
and root planing are implemented routinely in the initial management of chronic 
periodontitis
63
. 
As a result of the instrumentation, the periodontally affected root surfaces are cleared 
of the toxic deposits and a biologically favourable stratum is produced that facilitates 
periodontal tissue healing. In conjunction with supragingival plaque elimination, the 
significance of subgingival plaque removal is also paramount in eliminating the 
putative periodontal pathogenic microflora.  
The process of mechanical debridement is done with the use of scalers. They can be 
manual or power driven. The procedure is usually undertaken over several 
appointments in cases requiring full-mouth disinfection. It is performed on one 
quadrant at a time or on designated teeth at each visit. Root planing targets successful 
elimination and reduction in the quantity of periodontal pathogens. 
Clinical Parameters: 
In the present study only those patients were considered for non-surgical periodontal 
therapy who presented with chronic periodontitis having probing pocket depth of 
more than 5 mm and more than 10 sites. Oral hygiene status was assessed by 
calculating the plaque index at baseline and at 6 weeks following scaling and root 
planing. Plaque scores showed marked reductions over the 6 weeks period. 
DISCUSSION 
 
56 
 
The mean plaque index score reduced from a baseline score of 1.68 ± 0.32 to 0.38 ± 
0.12 at 6 weeks with a reduction of 1.30 ± 0.28. The mean Gingival Index score 
showed a decline from a baseline value of 1.73 ± 0.31 to 0.42 ± 0.14 at 6 weeks which 
is a difference of 1.32 ± 0.30. The mean Sulcular Bleeding Index score changed from 
2.03 ± 0.43 to 0.65 ± 0.38 over the 6 weeks following non-surgical therapy with a 
mean reduction of 1.38 ± 0.50.  
The mean Probing pocket depth clinically was in accordance with the other findings. 
It came down from 4.18 ± 1.13 to 3.24 ± 0.53, after treatment showing a mean 
decrease of 0.93 ± 0.81. The mean Clinical attachment level at baseline was 4.55 ± 
1.37 which was reduced to 3.68 ± 0.91 at 6 weeks showing a mean reduction of 0.87 
± 0.62. All these differences were statistically analysed by paired ‘t’ test and p value 
was obtained as 0.000 (p ˂0.05) which was found to be statistically significant, 
thereby validating our hypothesis. 
Lipid Profile Parameters: 
The mean Total cholesterol at baseline was 235.90 ± 57.66 which was reduced to 
196.74 ± 52.30 at 6 weeks showing a mean reduction of 39.16 ± 59.18 over this time 
period, which was statistically highly significant with the p value of 0.001. The initial 
Triglyceride levels of 221.71 ± 92.35 came down to 181.32 ± 72.21 showing a mean 
reduction of 40.39 ± 82.14, which was also significant with the p value of 0.010. The 
mean Low density lipoprotein changed from 145.52 ± 25.84 to 121.23 ± 29.38 over 
the course of the study showing a statistically significant decline of 24.29 ± 26.60  
(p value = 0.000). The Very low density lipoprotein at baseline was 44.95 ± 17.97 
which was reduced to 33.95 ± 12.25 at 6 weeks showing a mean reduction of 11.00 
±15.16 at 6 weeks, which was statistically highly significant with the p value of 0.000 
DISCUSSION 
 
57 
 
The mean High density lipoprotein level was the only value that showed an 
increase from a baseline value of 38.05 ± 6.57 to 43.98 ± 7.52 at 6 weeks with a 
mean increase of 5.94 ±8.44, also significant statistically.  
Review of current literature suggests a strong correlation of chronic periodontitis and 
the patients’ lipid levels. An investigation by Fentoğlu Ö et al in 20095 concluded 
that patients with hyperlipidemia displayed higher values of periodontal parameters 
namely, plaque index, pocket depth, clinical attachment level, bleeding on probing. 
Monteiro AM et al, in 2009
7
 noted higher levels of triglyceride and lower levels of 
high density lipoprotein in periodontitis patients. It was also reported by Sangwan A 
et al in 2013
6
 that probing depth and gingival index were expressively higher in 
patients with hyperlipidemia. On the corollary, there was also evidence of high serum 
cholesterol and total cholesterol being associated with periodontitis in otherwise 
healthy people as presented by Lal V et al in 2015
1
. It was corroborated by Seyoung 
Lee 2017
51
 who concluded that women with low HDL cholesterol levels showed 
significantly higher risk of periodontitis and those with high LDL cholesterol levels 
showed higher risk of the disease than those with high HDL and low LDL levels.  
The correlation between chronic periodontitis and hyperlipidemia was noticed and 
acted upon by Tuter G et al 2007
16
 who investigated the effect of non-surgical 
periodontal therapy on the lipid profile and observed that HDL cholesterol levels 
improved following sub-anti-microbial dose doxycycline adjunctive to scaling and 
root planing. 
Contrarily, a study by Sridhar R et al in 2009
34 
observed that periodontitis in a CHD 
patient did not seem to exacerbate the destruction of periodontal tissue and higher 
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triglyceride levels did not have any correlation with the severity of attachment loss in 
a periodontitis subject. 
There is also mixed evidence of this inter-relationship as noted by Rufail ML et al 
2007
30 
who observed progressively higher plasma levels of very low density 
lipoprotein and but smaller average low density lipoprotein size healthy with 
increasing severity of periodontitis. Very low density lipoprotein concentrations 
correlated positively with the periodontal pocket depth and negatively with average 
low density lipoprotein size. 
Through this study it is observed that chronic periodontitis patients present an altered 
lipid profile state and that a prompt non-surgical therapy alone would significantly 
restore the imbalance. This hyperlipidemic state could also act as a risk factor in 
development of cardiovascular disease which poses a high morbidity. Thus non-
surgical periodontal therapy alone has been found to have a beneficial effect on the 
lipid profile. The additional need for statins is thereby reduced by the favourable 
effects of non-surgical periodontal therapy. Within the limitations of the study, it can 
be concluded that through non-surgical periodontal therapy, there is a significant 
improvement in the lipid profile of an individual. 
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SUMMARY AND CONCLUSION: 
The present study was conducted to estimate the levels of lipid profile in patients with 
chronic periodontitis before and 6 weeks after scaling and root planing. The 
interrelationship is analyzed by calculating the changes in various clinical parameters 
like Plaque Index, Gingival Index, Sulcular Bleeding index, Probing Pocket depth and 
Clinical attachment level with respect to the variations in lipid profile.  
A total of 31 patients including both males and females aged between 30-60 years 
were selected. The study subjects were clinically (using UNC-15 probe) and 
biochemically (lipid profile) evaluated. These values were obtained before scaling and 
root planing and established as the baseline and a post-treatment recording was made 
6 weeks following non-surgical periodontal therapy for comparison with the baseline 
values. 
From the results of the study we arrive at the following conclusions: 
 There was a significant reduction in plaque index, gingival index, probing 
pocket depth following scaling and root planing over a six weeks’ time period. 
 There was a significant reduction in TC, TG, LDL, VLDL following scaling 
and root planing over this six weeks’ time period. 
 HDL values were found to be increased following scaling and root planing 
over the same time interval. 
 Thus a statistically significant correlation is established between the 
Clinical attachment level parameters and the Lipid profile of the 
individuals under study. 
 Thus, Scaling and root planing are effective non-surgical means of 
improving the lipid profile towards a healthy state. 
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ANNEXURE 2 
INFORMED CONSENT FORM 
 
 
Name: Mr/Ms/Mrs                                                           OP.No: 
Address:              SEX: Male/Female 
AGE:      Years 
 
 
 
 
I, ------------------------------------------------------, exercising my free power of choice, 
hereby give my consent to be included as a participant in the study. 
 
I agree to the following: 
 
1. I have been informed to my satisfaction about the purpose of the study and 
procedures. 
 
2. I understand that the study involves questions which may sometimes be personal. 
 
3. I agree to co-operate fully for complete examination. 
 
4. I agree to give my Blood sample for investigation. 
 
5. I agree to report to my doctor for a regular follow up and when required for the 
research. 
 
6. I have informed my doctor about all the medications that I am currently taking. 
 
7. I hereby give permission to use my medical records for research purpose. I have 
been told that the investigating doctor and the institution will keep my identity 
confidential. 
 
8. I understand that I have rights to withdraw myself from the study and also that the 
investigator has the right to exclude me from the research at any point of time. 
 
Hereby we advise the patients to consult their physician regarding elevated lipid 
profile  
INVESTIGATOR:                                                                                              
SIGNATURE OF THE PARTICIPANT: 
 
Signature/Thumb impression      Signature 
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ANNEXURE 4 
LEVELS OF LIPID PROFILE IN PATIENTS WITH CHRONIC 
PERIODONTITIS 
BEFORE AND AFTER SCALING AND ROOT PLANING - 
A COMPARATIVE STUDY 
                                                     PROFORMA 
Op No:                                                                                                           
SL No: 
Date:       
Name:       
Age/ Sex: 
Address:     
Occupation:  
Socioeconomic status: 
Chief Complaint: 
Medical history: 
Personal History: 
 
 
 
ANNEXURE 
 
 
PLAQUE INDEX (SILNESS & LOE 1964) – BASELINE 
 
SCORE =EXCELLENT/GOOD/ FAIR / POOR 
 
PLAQUE INDEX (SILNESS & LOE 1964) – AFTER SIX WEEKS 
 
SCORE =EXCELLENT/GOOD/ FAIR / POOR 
                                          
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
                                          
              
                                          
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
                                          
              
B 
P 
B 
P 
B 
P 
B 
P 
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GINGIVAL INDEX (LOE AND SILNESS 1963) - BASELINE 
 
SCORE =EXCELLENT/GOOD/ FAIR / POOR 
 
GINGIVAL INDEX (LOE AND SILNESS 1963) - AFTER SIX WEEKS 
 
SCORE =EXCELLENT/GOOD/ FAIR / POOR 
                                          
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
                                          
              
                                          
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
                                          
              
B 
P 
B 
P 
B 
P 
B 
P 
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SULCULAR BLEEDING INDEX (MUHLEMAN H.R. &SON S.1971) –
BASELINE  
 
Score: 
 
SULCULAR BLEEDING INDEX (MUHLEMAN H.R. &SON S.1971) –
AFTER SIX WEEKS  
 
 
Score: 
 
 
 
                
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
                
                
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
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PROBING POCKET DEPTH – BASELINE  
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
                
                
                
                
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
 
CLINICAL ATTACHMENT LEVEL - BASE LINE 
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
                
                
                
                
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
 
PROBING POCKET DEPTH - AFTER SIX WEEKS 
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
                
                
                
                
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
 
CLINICAL ATTACHMENT LEVEL – AFTER SIX WEEKS 
18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28 
                
                
                
                
48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38 
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BIOCHEMICAL PARAMETERS 
LIPID PROFILE BASELINE AFTER SIX 
WEEKS 
TOTAL CHOLESTEROL   
TRIGLYCERIDE   
LOW DENSITY LIPOPROTEIN   
VERY LOW DENSITY 
LIPOPROTEIN 
  
HIGH DENSITY LIPOPROTEIN   
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PARAMETERS BASELINE AFTER SIX 
WEEKS 
PLAQUE INDEX 
(SILNESS & LOE 1964) 
  
GINGIVAL INDEX 
(LOE AND SILNESS 1963) 
  
SULCULAR BLEEDING INDEX 
(MUHLEMAN & SON 1971) 
  
PROBING POCKET DEPTH  
(mm) 
  
CLINICAL ATTACHMENT 
LEVEL 
(mm) 
  
TOTAL CHOLESTEROL 
(mg/dl) 
  
TRIGLYCERIDE 
(mg/dl) 
  
LOW DENSITY LIPOPROTEIN 
(mg/dl) 
 
VERY LOW DENSITY  
LIPOPROTEIN 
(mg/dl) 
  
HIGH DENSITY  
LIPOPROTEIN 
(mg/dl) 
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DATE TREATMENT DONE STAFF INCHARGE 
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ANNEXURE 5 
    MASTER CHART 
S. 
NO 
SEX AGE PI GI SBI 
Base Line After 
6 wk 
Base Line After 
6 wk 
Base Line After 
6 wk 
1 M 36 1.53 0.5 1.44 0.47 1.18 0.76 
2 M 31 1.64 0.31 1.69 0.3 1.87 0.64 
3 F 40 1.55 0.47 1.9 0.4 2.7 0.55 
4 M 46 1.8 0.26 1.79 0.36 1.37 0.48 
5 M 36 1.28 0.34 1.39 0.42 1.46 0.49 
6 M 57 1.62 0.26 1.83 0.3 2.1 1.07 
7 M 39 1.45 0.28 1.8 0.3 2.4 0.8 
8 M 49 2 0.26 1.94 0.27 1.6 0.79 
9 M 44 1.9 0.38 1.56 0.44 2.4 0.77 
10 F 32 1.35 0.32 1.65 0.61 1.6 0.76 
11 M 44 1.9 0.49 2.9 0.48 2.3 0.6 
12 F 44 1.9 0.4 1.8 0.3 2.1 0.36 
13 F 36 2 0.36 1.88 0.34 2.3 0.37 
14 M 55 2 0.5 1.9 0.5 2.4 0.5 
15 M 45 1.9 0.4 1.9 0.5 2 0.3 
16 M 35 1.7 0.52 1.6 0.54 1.8 0.58 
17 F 33 1.6 0.47 1.6 0.35 1.48 0.72 
18 F 46 1.84 0.5 1.33 0.3 1.55 0.44 
19 M 33 1.8 0.41 1.7 0.38 2.5 0.5 
20 M 41 1.75 0.61 1.79 0.46 2.17 0.66 
21 M 35 1.95 0.47 1.69 0.34 2.56 0.67 
22 M 40 0.87 0.089 1.46 0.7 2.18 0.67 
23 M 30 1.88 0.45 1.78 0.47 2.13 0.71 
24 F 40 1 0.12 1.2 0.11 1.1 0.14 
25 M 38 2.16 0.4 2.08 0.5 2.16 0.55 
26 F 36 1.89 0.45 1.92 0.48 2.27 0.51 
27 M 52 1.8 0.36 1.83 0.76 2.56 0.61 
28 F 36 2 0.36 1.87 0.51 2.35 0.6 
29 M 31 1.75 0.36 1.87 0.45 2.5 2.49 
30 M 42 1.08 0.23 1.3 0.18 2.08 0.5 
31 F 46 1.2 0.4 1.3 0.35 1.76 0.55 
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S. 
NO 
SEX AGE PPD CAL 
Base Line After 
6 wk 
Base Line After 
6 wk 
1 M 36 3.7 2.9 5.5 4.5 
2 M 31 4.62 3.98 5.8 4.88 
3 F 40 4.3 3.57 6.16 4.87 
4 M 46 2.6 2.58 2.51 2.65 
5 M 36 4.3 3.52 4.28 3.33 
6 M 57 3.7 3.17 5 4.4 
7 M 39 5.2 3.1 7.6 5.5 
8 M 49 5.7 3.3 5.5 3.6 
9 M 44 3.1 2.7 3.5 3 
10 F 32 4.9 3.9 4.9 3.7 
11 M 44 6.3 4.3 6.7 4.9 
12 F 44 6.3 4.3 6.7 4.9 
13 F 36 3.5 3.2 3.5 3.2 
14 M 55 3.5 3.2 3.5 3.2 
15 M 45 3.05 2.5 3.05 2.5 
16 M 35 3.2 2.9 3.2 2.9 
17 F 33 3.2 2.7 3.2 2.7 
18 F 46 5.7 4.17 6.39 5.26 
19 M 33 4.6 3.7 4.5 3.7 
20 M 41 4.03 3.14 4.58 3.85 
21 M 35 4.02 3.17 4.21 3.32 
22 M 40 3.47 2.97 3.72 3.19 
23 M 30 5.34 3.74 4.46 4.17 
24 F 40 3 2.5 3 2.47 
25 M 38 2.72 2.52 2.81 2.44 
26 F 36 5.34 3.77 6.74 4.75 
27 M 52 3.66 2.99 3.11 2.98 
28 F 36 6.4 2.8 4.69 2.8 
29 M 31 2.87 2.93 4.46 3.35 
30 M 42 3.3 3 3.2 3 
31 F 46 3.82 3.37 4.62 4.2 
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S. 
NO 
SEX AGE TC TRI LDL 
Base 
Line 
After 
6 wk 
Base 
Line 
After 
6 wk 
Base 
Line 
After 
6 wk 
1 M 36 240 220 220 150 159 138 
2 M 31 300 265 185 175 174 160 
3 F 40 185 180 290 115 120 120 
4 M 46 320 181 300 399 160 70 
5 M 36 192 240 143 160 125 156 
6 M 57 250 207 115 93 160 155 
7 M 39 240 265 370 220 172 165 
8 M 49 270 210 470 200 180 135 
9 M 44 250 230 240 210 146 135 
10 F 32 150 120 130 115 105 102 
11 M 44 180 155 345 214 98 95 
12 F 44 85 110 272 260 68 60 
13 F 36 285 235 190 130 165 130 
14 M 55 232 170 154 140 154 120 
15 M 45 225 142 174 161 144 95 
16 M 35 205 186 106 120 155 118 
17 F 33 340 240 150 140 180 160 
18 F 46 305 260 234 120 168 165 
19 M 33 235 107 110 240 135 66 
20 M 41 200 320 400 280 140 128 
21 M 35 165 220 210 115 150 102 
22 M 40 178 176 292 133 120 110 
23 M 30 269 120 149 110 160 94 
24 F 40 238 153 290 328 160 85 
25 M 38 228 215 195 192 146 120 
26 F 36 320 180 105 145 150 120 
27 M 52 164 120 160 153 102 98 
28 F 36 240 192 160 143 156 125 
29 M 31 240 220 220 150 159 138 
30 M 42 312 250 306 305 154 153 
31 F 46 270 210 188 205 146 140 
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S. 
NO 
SEX AGE VLDL HDL 
Base Line After 
6 wk 
Base Line After 
6 wk 
1 M 36 44 30 37 47 
2 M 31 37 32 37 48 
3 F 40 58 23 44 33 
4 M 46 60 44 52 67 
5 M 36 28.6 32 38.4 42 
6 M 57 23 19 46 48 
7 M 39 74 44 38 48 
8 M 49 94 40 50 46 
9 M 44 48 42 38 48 
10 F 32 26 23 35 40 
11 M 44 69 43 40 36 
12 F 44 55 45 26 36 
13 F 36 38 26 40 47 
14 M 55 31 28 33 38 
15 M 45 35 33 30 48 
16 M 35 39 24 35 59 
17 F 33 30 20 38 48 
18 F 46 47 24 30 42 
19 M 33 22 48 28 33 
20 M 41 80 56 36 48 
21 M 35 42 23 33 48 
22 M 40 58 27 37 45 
23 M 30 30 22 30 42 
24 F 40 58 66 40 38 
25 M 38 39 38 30 36 
26 F 36 21 29 48 43 
27 M 52 32 31 38 46 
28 F 36 32 28.6 42 38.4 
29 M 31 44 30 37 47 
30 M 42 61 61 48 48 
31 F 46 38 21 45 30 
 
 
 
